These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19390070)

  • 21. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
    Henneman WJ; Sluimer JD; Cordonnier C; Baak MM; Scheltens P; Barkhof F; van der Flier WM
    Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
    Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
    Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design, and methodology.
    Yamano S; Horii M; Takami T; Sakuma M; Morimoto T; Okada S; Taoka T; Kichikawa K; Sasamura H; Itoh H; Furuya Y; Ueno S; Imamura T; Sugiyama S; Ogawa H; Saito Y
    Int J Stroke; 2015 Apr; 10(3):452-6. PubMed ID: 23834197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
    den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
    Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.
    Jokinen H; Kalska H; Mäntylä R; Ylikoski R; Hietanen M; Pohjasvaara T; Kaste M; Erkinjuntti T
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1229-33. PubMed ID: 16107356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.
    Debette S; Markus HS
    BMJ; 2010 Jul; 341():c3666. PubMed ID: 20660506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
    van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
    Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity of White Matter Hyperintensities and Length of Hospital Stay in Patients with Cognitive Impairment: A CREDOS (Clinical Research Center for Dementia of South Korea) Study.
    Chang KJ; Lee S; Lee Y; Lee KS; Back JH; Jung YK; Lim KY; Noh JS; Kim HC; Roh HW; Choi SH; Kim SY; Joon Son S; Hong CH
    J Alzheimers Dis; 2015; 46(3):719-26. PubMed ID: 25854927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities.
    Noh Y; Lee Y; Seo SW; Jeong JH; Choi SH; Back JH; Woo SY; Kim GH; Shin JS; Kim CH; Cho H; Park JS; Lee JM; Hong CH; Kim SY; Lee JH; Kim SY; Park KH; Han SH; Cheong HK; Na DL
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):636-42. PubMed ID: 23867045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of intracranial atherosclerotic stenosis with severity of white matter hyperintensities.
    Park JH; Kwon HM; Lee J; Kim DS; Ovbiagele B
    Eur J Neurol; 2015 Jan; 22(1):44-52, e2-3. PubMed ID: 24712717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of prestroke cognitive impairment in stroke associated with small vessel disease.
    Mok V; Wong A; Tang WK; Lam WW; Fan YH; Richards PS; Wong KT; Ahuja AT; Wong KS
    Dement Geriatr Cogn Disord; 2005; 20(4):225-30. PubMed ID: 16088138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulse Pressure and Cognitive Decline in Stroke Patients With White Matter Changes.
    Wang Z; Wong A; Liu W; Yang J; Chu WC; Au L; Lau A; Xiong Y; Mok VC
    J Clin Hypertens (Greenwich); 2015 Sep; 17(9):694-8. PubMed ID: 26033405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study.
    Dufouil C; Fuhrer R; Alpérovitch A
    J Am Geriatr Soc; 2005 Apr; 53(4):616-21. PubMed ID: 15817007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease.
    Kitagawa K; Oku N; Kimura Y; Yagita Y; Sakaguchi M; Hatazawa J; Sakoda S
    Hypertens Res; 2009 Sep; 32(9):816-20. PubMed ID: 19575014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.
    van der Veen PH; Muller M; Vincken KL; Hendrikse J; Mali WP; van der Graaf Y; Geerlings MI;
    Stroke; 2015 May; 46(5):1233-8. PubMed ID: 25804924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline.
    Benedictus MR; van Harten AC; Leeuwis AE; Koene T; Scheltens P; Barkhof F; Prins ND; van der Flier WM
    Stroke; 2015 Sep; 46(9):2661-4. PubMed ID: 26173729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and cognitive impact of medial temporal atrophy in a hospital stroke service: retrospective cohort study.
    Kebets V; Gregoire SM; Charidimou A; Barnes J; Rantell K; Brown MM; Jäger HR; Cipolotti L; Werring DJ
    Int J Stroke; 2015 Aug; 10(6):861-7. PubMed ID: 26043795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.